| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.38B | $1.35B | $1.28B |
| YoY Revenue Growth % | +2.5% | +5.1% | — |
| Gross Profit | $322.2M | $339.1M | — |
| Gross Margin % | 23.3% | 25.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$63.5M | -$100.7M | -$36.4M |
| Operating Margin % | -4.6% | -7.5% | -2.8% |
| Net Income (GAAP) | -$373.4M | -$152.9M | -$116.5M |
| EBITDA (Normalized) | -$57.4M | -$98.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $11.2M | $17.9M | $14.8M |
| Capital Expenditures (CapEx) | $7.6M | $2.4M | — |
| Free Cash Flow (FCF) | $3.6M | $15.5M | $14.8M |
| FCF Margin % | 0.3% | 1.1% | 1.2% |
| Return on Invested Capital (ROIC %) | -8.5% | -8.8% | — |
| Cash & Short-Term Equivalents | $581.8M | $572.4M | — |
| Total Debt (Short + Long Term) | — | $0 | — |
| Total Stockholders' Equity | $1.17B | $1.47B | — |